Skip to main content

Effects of Formulation Variables on the Formation of Nanoparticles Prepared from L-Lactide-Depsipeptide Copolymer

Buy Article:

$113.00 plus tax (Refund Policy)

Abstract:

A depsipeptide-lactide copolymer, poly[LA-(Glc-Leu)], was obtained by ring opening copolymerization of L-lactide with a cyclodepsipeptide, cyclo(Glc-Leu). Poly[LA-(Glc-Leu)] nanoparticles were prepared by the oil-in-water solvent evaporation method using Diclofenac Sodium as model hydrophilic drug. In order to both reaching submicron size as well as increasing the grade of monodispersity compared to previous preparation techniques, a microfluidizer as probe ultrasonication device was used. The ultrasonication procedure has been optimized with regard to particle size and monodispersity by changing the different formulation parameters during the preparation step. The drug loading has been improved by varying the concentration of the drug in organic phase. The diclofenac encapsulation efficiency decreased with higher drug concentration in the inner organic phase. The release profile of optimized batch was characterized by a initial burst effect followed by extended release. To estimate main-chain cleavage behavior of optimized polymeric nanoparticles in vivo, the hydrolysis of the particles in vitro was carried out in phosphate buffer with or without Protinease K.

Keywords: DICLOFENAC SODIUM; EMULSION AND SOLVENT EVAPORATION; ENCAPSULATION; NANOPARTICLES; POLY[LA-(GLC-LEU)]

Document Type: Research Article

DOI: https://doi.org/10.1166/jbn.2006.034

Publication date: 2006-10-01

More about this publication?
  • Journal of Biomedical Nanotechnology (JBN) is a peer-reviewed multidisciplinary journal providing broad coverage in all research areas focused on the applications of nanotechnology in medicine, drug delivery systems, infectious disease, biomedical sciences, biotechnology, and all other related fields of life sciences.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free ContentFree content
  • Partial Free ContentPartial Free content
  • New ContentNew content
  • Open Access ContentOpen access content
  • Partial Open Access ContentPartial Open access content
  • Subscribed ContentSubscribed content
  • Partial Subscribed ContentPartial Subscribed content
  • Free Trial ContentFree trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more